Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-01-04 @ 7:08 PM
Study NCT ID:
NCT00470704
Status:
COMPLETED
Last Update Posted:
2024-12-19
First Post:
2007-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Sponsor:
Nancy Lin, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
06-213
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None